Dr. Gerber is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
28155 Tomball Pkwy
#4
Tomball, TX 77375Phone+1 281-290-7200
Education & Training
East Tennessee State University/Quillen College of MedicineResidency, Surgery, 1984 - 1986
The University of Texas Health Science Center at San AntonioClass of 1984
Certifications & Licensure
OK State Medical License 1992 - 2026
TX State Medical License 1985 - 2025
TN State Medical License 1984 - 1992
Clinical Trials
- Phase 1/2 Trial of Selinexor (KPT-330) With Docetaxel for Non-small Cell Lung Cancer (NSCLC) Start of enrollment: 2018 Mar 22
Publications & Presentations
PubMed
- 7 citationsClinician Variation in Ordering and Completion of Low-Dose Computed Tomography for Lung Cancer Screening in a Safety-Net Medical System.David E. Gerber, Heidi A. Hamann, Olivia Dorsey, Chul Ahn, Jessica L. Phillips
Clinical Lung Cancer. 2021-07-01 - 17 citationsExperience, Perceptions, and Recommendations Concerning COVID-19-Related Clinical Research Adjustments.David E. Gerber, Thomas Sheffield, M. Shaalan Beg, Erin L Williams, Valerie L Clark
Journal of the National Comprehensive Cancer Network. 2021-05-01 - 16 citationsModernizing clinical trial eligibility criteria: Recommendations of the ASCO-friends of cancer research laboratory reference ranges and testing intervals work groupAlexander I. Spira, Mark Stewart, Suzanne F. Jones, Elaine Chang, Anitra Fielding
Clinical Cancer Research. 2021-05-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
